English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Chromosome 4q deletion is one of the most frequently detected genomic imbalance events in congenital heart disease (CHD) patients. However, a portion of CHD-associated 4q deletions without known CHD genes suggests unknown CHD genes within these intervals. Here, we have shown that knockdown of  SORBS2 , a 4q interval gene, disrupted sarcomeric integrity of cardiomyocytes and caused reduced cardiomyocyte number in human embryonic stem cell differentiation model. Molecular analyses revealed decreased expression of second heart field (SHF) marker genes and impaired NOTCH and SHH signaling in  SORBS2- knockdown cells. Exogenous SHH rescued  SORBS2  knockdown-induced cardiomyocyte differentiation defects.  Sorbs2 -/-   mouse mutants had atrial septal hypoplasia/aplasia or double atrial septum (DAS) derived from impaired posterior SHF with a similar expression alteration. Rare  SORBS2  variants were significantly enriched in a cohort of 300 CHD patients. Our findings indicate that  SORBS2  is a regulator of SHF development and its variants contribute to CHD pathogenesis. The presence of DAS in  Sorbs2 -/-   hearts reveals the first molecular etiology of this rare anomaly linked to paradoxical thromboembolism.

SORBS2 is a genetic factor contributing to cardiac malformation of 4q deletion syndrome patients